Renalytix expands US footprint with three new clinical partnerships
Renalytix PLC (AIM:RENX, OTC:RNLXY), the diagnostics company behind the kidney disease risk test kidneyintelX.dkd, has signed up three more US…
0,072€
7,04%
Echtzeit-Aktienkurs Renalytix AI PLC
Bid:
Ask:
Nachrichten zur Renalytix AI PLC Aktie
Form 8.5 (EPT/RI) - Renalytix Plc
FORM 8.5 (EPT/RI) …
Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript
…